Clinical Evaluation of Herbal Medicine (ICH-012) in Treating Acute Cerebral Haemorrhage: Safety and Efficacy from 6- to 72-Hour Time Window (CRRICHTrial-II)

Qixin Zhang, Liling Zeng, Xiuyan Chen, Yuexiang Zhou, Baoying Gong, Haijun Li, Jianwen Guo, Qixin Zhang, Liling Zeng, Xiuyan Chen, Yuexiang Zhou, Baoying Gong, Haijun Li, Jianwen Guo

Abstract

Background: Hypertensive intracerebral haemorrhage (HICH), which is characterized by rapid change, high morbidity, and mortality, is extremely dangerous. Both medical and surgical treatments lack definitive evidence and remain controversial. A prospective RCT that we have conducted has shown that the usage of the herbal medicine ICH-012 within 6 h of the event may increase the risk of haematoma enlargement and gastrointestinal bleeding. However, the volume of haematoma remains stable after 6 h. Thus, we will increase the time window to the period from 6 to 72 h after onset to evaluate the safety and efficacy of ICH-012 treating ICH (ClinicalTrial.gov ID: NCT03354026).

Methods/design: The CRRICHTrial-II study, a prospective, double-blinded, controlled, multicentre RCT, includes three groups: A, B, and C. Group A patients were treated with 8 herbal medicines (with 2 herbal medicines of Hirudo and Tabanus as well as 6 other combined herbal medicines of Group B) and Group C were placebo. Patients should meet all the inclusion criteria: age between 18 and 80 and diagnosis of HICH by brain CT scan between 6 and 72 h from the onset. The CT scan will be taken at four critical time points: baseline, between 6 and 72h, 24h after onset, and between 10 and 14 days after onset. The drug intervention lasts 10 days, and there is a follow-up visit taken after 90 days. The haematoma enlargement after 24 h onset as demonstrated by CT is the primary outcome.

Discussion: A large amount of data from high-quality RCTs is needed for the extensive clinical application of herbal medicine. The CRRICHTrial-II will evaluate the safety and effectiveness of ICH-012 in a safer time window between 6 and 72 h and investigate the possible mechanisms of action and direction of herbal medicine in the haematoma growth after HICH. Trial registration at ClinicalTrial.gov, ID: NCT03354026, is registered on 23rd Nov. 2017.

Figures

Figure 1
Figure 1
The flowchart of the CRRICHTrial-II.

References

    1. GBD 2015 Mortality and Causes of Death Collaboratiors Global. Regional, and national life expectancy, all-causes mortality, and cause-specific mortality for 249 causes of death.1980-2015:a systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet.2016,388;1459-1544.
    1. Wang W., Jiang B., Sun H., et al. Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480 687 Adults. Circulation. 2017;135(8):759–771. doi: 10.1161/CIRCULATIONAHA.116.025250.
    1. Hemphill J. C., III, Greenberg S. M., Anderson C., et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–2060. doi: 10.1161/STR.0000000000000069.
    1. Rodriguez-Luna D., Coscojuela P., Rubiera M., et al. Ultraearly hematoma growth in active intracerebral hemorrhage. Neurology. 2016;87(4):357–364. doi: 10.1212/WNL.0000000000002897.
    1. Kong Yu., Yan Bo., Guoqing Z., et al. Analysis of the time process and related factors of hematoma enlargement after acute cerebral hemorrhage. Jinagsu Medical Journal. 2015;41(24):3032–3033.
    1. Wada R., Aviv R. I., Fox A. J., et al. CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke. 2007;38(4):1257–1262. doi: 10.1161/01.STR.0000259633.59404.f3.
    1. Porto G. B. F., Spiotta A. M., Chalela J. A., Kellogg R. T., Jauch E. C. Blood Pressure Guideline Adherence in Patients with Ischemic and Hemorrhagic Stroke in the Neurointensive Care Unit Setting. Neurocritical Care. 2015;23(3):313–320. doi: 10.1007/s12028-015-0116-y.
    1. Emiru T., Bershad E. M., Zantek N. D., et al. Intracerebral hemorrhage: A review of coagulation function. Clinical and Applied Thrombosis/Hemostasis. 2013;19(6):652–662. doi: 10.1177/1076029612454938.
    1. Greenberg S. M., Vonsattel J. G., Segal A. Z., et al. Association of apolipoprotein E 2 and vasculopathy in cerebral amyloid angiopathy. Neurology. 1998;50(4):961–965. doi: 10.1212/WNL.50.4.961.
    1. Brouwers H. B., Biffi A., Ayres A. M., et al. Apolipoprotein e genotype predicts hematoma expansion in lobar intracerebral hemorrhage. Stroke. 2012;43(6):1490–1495. doi: 10.1161/STROKEAHA.111.643262.
    1. Misra U. K., Kalita J., Somarajan B. I. Recurrent intracerebral hemorrhage in patients with hypertension is associated with APOE gene polymorphism: A preliminary study. Journal of Stroke and Cerebrovascular Diseases. 2013;22(6):758–763. doi: 10.1016/j.jstrokecerebrovasdis.2012.02.006.
    1. Steiner T., Vincent C., Morris S., Davis S., Vallejo-Torres L., Christensen M. C. Neurosurgical outcomes after intracerebral hemorrhage: Results of the Factor Seven for Acute Hemorrhagic Stroke Trial (FAST) Journal of Stroke and Cerebrovascular Diseases. 2011;20(4):287–294. doi: 10.1016/j.jstrokecerebrovasdis.2009.12.008.
    1. Saxena A., Anderson C. S., Wang X., et al. Prognostic Significance of Hyperglycemia in Acute Intracerebral Hemorrhage. Stroke. :p. STROKEAHA.115.011627. doi: 10.1161/STROKEAHA.115.011627.
    1. Mendelow A. D., Gregson B. A., Rowan E. N., Murray G. D., Gholkar A., Mitchell P. M. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. The Lancet. 2013;382(9890):397–408. doi: 10.1016/s0140-6736(13)60986-1.
    1. The national 8th five-year key research project, Ren, Runquan Jin, , Broken blood stasis, purging heat, Xingshen phlegm resuscitation in treatment of hemorrhagic stroke in acute stage patients with 222 focuses on clinical [C]// Research Institute of the State Administration of traditional Chinese medicine encephalopathy construction seminar and stroke research to promote the exchange of the,
    1. Offiah C., Heran M., Graeb D. Lightning strike: a rare cause of bilateral ossicular disruption. American Journal of Neuroradiology. 2007;28(5):974–975.
    1. Xu Yafa, Guo Jianwen, Liu Xian, Li Juehu, I, Wang Jing, Hou Lingbo. Can Herbal Medicine Cause Hematoma Enlargement of Hypertensive Intracerebral Hemorrhage within 24 hrs Time Window? A Retrospective Study of 256 Cases from a Single Center in China. Evidence-Based Complementary and Alternative Medicine. 2015;2015:8. doi: 10.1155/2015/868731.868731
    1. Liling Z. Treatment of hyperacute cerebral hemorrhage in the treatment of hyperacute cerebral hemorrhage: a multicenter randomized controlled clinical study. Guangzhou, China: Guangzhou University of Chinese Medicine; 2017.
    1. Fujii Y., Tanaka R., Takeuchi S., Koike T., Minakawa T., Sasaki O. Hematoma enlargement in spontaneous intracerebral hemorrhage. Journal of Neurosurgery. 1994;80(1):51–57. doi: 10.3171/jns.1994.80.1.0051.
    1. Fujii Y., Takeuchi S., Sasaki O., Minakawa T., Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke. 1998;29(6):1160–1166. doi: 10.1161/01.STR.29.6.1160.
    1. Fujitsu K., Muramoto M., Ikeda Y., Inada Y., Kim I., Kuwabara T. Indications for surgical treatment of putaminal hemorrhage: Comparative study based on serial CT and time-course analysis. Journal of Neurosurgery. 1990;73(4):518–525. doi: 10.3171/jns.1990.73.4.0518.
    1. Neurology branch of the Chinese Medical Association. Guidelines for the diagnosis and treatment of cerebral hemorrhage in China (2014). Journal of Chinese neurology, 2015, 48 (6): 435-444.
    1. Wang X. W. Study on Molecular Predictive Biomarkers For Early Hematoma Growth of Intracerebral hemorrhage. Chinese Journal of Stroke. 2009
    1. Biffi A., Anderson C. D., Jagiella J. M., et al. APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: A genetic association study. The Lancet Neurology. 2011;10(8):702–709. doi: 10.1016/S1474-4422(11)70148-X.
    1. Appelboom G., Piazza M., Han J. E., et al. Von Willebrand factor genetic variant associated with hematoma expansion after intracerebral hemorrhage. Journal of Stroke and Cerebrovascular Diseases. 2013;22(6):713–717. doi: 10.1016/j.jstrokecerebrovasdis.2011.10.018.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться